Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude

Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude in Diqing Tibetan Autonomous Prefecture, Yunnan Province

Microbes and the human body maintain a complex relationship of interaction and influence. Different regions, altitudes, and dietary habits have different degrees of influence on the composition of children's intestinal flora. Therefore, the development and maturation process of children's intestinal flora in plateau areas was discovered, and its relationship with children's immunity, metabolism, and growth was understood. The mechanism of action of children's intestinal flora on immunity, growth and development was further analyzed by comparing it with people in low-altitude areas, to provide a scientific basis for improving children's health in plateau areas.

Study Overview

• Status: Recruiting
• Conditions: Children, Only; Gut Microbiota; Health

Detailed Description

This observational study aims to gain a deeper understanding of the interactions and influence of microbes on the human body. By comparing the gut microbiota composition of children in different regions, at varying altitudes, and with distinct dietary habits, the study aims to answer two key questions:

What are the characteristics of children's gut microbiota in different regions, at different altitudes, and with different dietary habits? What is the relationship between the development and maturation process of children's gut microbiota in plateau areas and their immunity, metabolism, and growth? Participants will be asked to provide fecal samples for analysis during the study. They may also be asked to answer questionnaires about their lifestyle factors such as diet and physical activity. The comparison group is included, researchers will compare the gut microbiota composition and diversity of children in low-altitude areas with those in plateau areas to assess any differences in their gut microbiota profiles. By comparing these differences, the mechanism of action of children's gut microbiota on immunity, growth and development can be further analyzed. The findings of this study aim to provide a scientific basis for improving children's health in plateau areas.

• Study Type: Observational
• Enrollment (Estimated): 300

Contacts and Locations

• Study Contact: Name: Xinqiong Wang; Phone Number: 600905 0086-021-64370045; Email: wxq11671@rjh.com.cn

Study Locations

• China
  • Shanghai
    • Shanghai, Shanghai, China, 021
      • Recruiting
      • Ruijin Hospital, Shanghai Jiaotong University School Of Medicine
      • Contact: Xinqiong Wang; Phone Number: 600905 0086-021-64370045; Email: wxq11671@rjh.com.cn

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

heathy children aged 1-3 years old

Description

Inclusion Criteria:

• Children aged 1-3 years old
• Both men and women;
• The child's legal guardian signed the informed consent to participate in the study.
• The legal guardian of the child commits to follow the study procedures and cooperate with the entire study process

Exclusion Criteria:

• Probiotics or antibiotics within 1 month
• Associated with clinically significant abnormalities in liver and kidney function, nervous system, respiratory system, and coagulation function as determined by the investigator
• Unstable vital signs;
• Have other underlying medical conditions
• Individuals deemed unsuitable for this clinical trial.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
High-altitude; Children live in a high-altitude area of more than 3000 meters.
Low-altitude; Children live in a low-altitude area of less than 500 meters.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intestinal microbiome analysis by high-throughput metagenomic	The fecal samples from all participants will be collected and subjected to high-throughput metagenomic sequencing in order to elucidate the characteristics and composition of the intestinal microbiome in children residing at different altitudes	0-7 days after enrolled

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intestinal microbiome metabolites analysis	This will be detected and analyzed by liquid chromatography-mass spectrometry (LC-MS) non-targeted metabolomics to analyze the metabolites of the intestinal microbiome and compare the differences in these metabolites among children at different altitudes.	0-7 days after enrolled

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
The percentile number of height of children at different altitudes	Compare the Percentile number of height of children at different altitudes	0-7 days after enrolled
The percentile number of weight of children at different altitudes	Compare the Percentile number of weight of children at different altitudes	0-7 days after enrolled
The percentile number of head circumference of children at different altitudes	Compare the Percentile number of head circumference of children at different altitudes	0-7 days after enrolled

Collaborators and Investigators

• Sponsor: Ruijin Hospital
• Investigators: Principal Investigator: Chundi Xu, Ruijin Hospital

Study record dates

Study Major Dates

• Study Start (Actual): October 16, 2023
• Primary Completion (Estimated): December 31, 2025
• Study Completion (Estimated): August 31, 2026

Study Registration Dates

• First Submitted: November 8, 2023
• First Submitted That Met QC Criteria: November 27, 2023
• First Posted (Estimated): December 5, 2023

Study Record Updates

• Last Update Posted (Estimated): December 5, 2023
• Last Update Submitted That Met QC Criteria: November 27, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: SYJQ-001

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No